Open AccessPD10-08 ABIRATERONE ACETATE (AA) + PREDNISOLONE (P) FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) WITH EARLY PROGRESSION OR NO-RESPONSE TO ANDROGEN DEPRIVATION THERAPY (ADT); FINAL ANALYSIS
Author(s) -
Hiroomi Nakatsu,
Akimitsu Maniwa,
Naoto Kamiya,
Mizue Ogi,
Hisanori Kobayashi,
Masahiko Nakayama
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.618
Subject(s) - abiraterone acetate , medicine , prostate cancer , androgen deprivation therapy , enzalutamide , oncology , abiraterone , randomized controlled trial , cancer , androgen receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom